Interferon alfa-2a in the treatment of ocular Adamantiades-Behçet's disease

Adv Exp Med Biol. 2003:528:511-9. doi: 10.1007/0-306-48382-3_103.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Angiogenesis Inhibitors / administration & dosage
  • Angiogenesis Inhibitors / adverse effects
  • Angiogenesis Inhibitors / therapeutic use
  • Behcet Syndrome / drug therapy*
  • Behcet Syndrome / physiopathology*
  • Eye Diseases / drug therapy*
  • Eye Diseases / etiology
  • Fluorescein Angiography
  • Follow-Up Studies
  • Humans
  • Injections, Subcutaneous
  • Interferon alpha-2
  • Interferon-alpha / administration & dosage
  • Interferon-alpha / adverse effects
  • Interferon-alpha / therapeutic use*
  • Male
  • Optic Nerve Diseases / drug therapy
  • Optic Nerve Diseases / etiology
  • Recombinant Proteins
  • Time Factors
  • Treatment Outcome
  • Visual Acuity*

Substances

  • Angiogenesis Inhibitors
  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins